Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation of bioinformatics-based m6A methylation regulators with prognosis in oral squamous cell carcinoma patients. | J Craniomaxillofac Surg | 2026 | 41455610 | PubTator, text mining | PubMed |
| Epitranscriptomic modifications in embryonic development: insights into natural and ART-induced mechanisms and implications. | Hum Reprod Update | 2026 | 41445111 | PubTator, text mining | PubMed |
| The progress of m6A methylation-regulated non-coding RNAs in osteogenic differentiation and osteoporosis. | Noncoding RNA Res | 2026 | 41439031 | PubTator, text mining | PubMed |
| m6A-metabolite axes in depression: METTL14 network dysregulation and RBM15 lipid protection. | J Affect Disord | 2026 | 41429321 | PubTator, text mining | PubMed |
| 17-AAG promotes the degradation of HSP90 client METTL3 to suppress MYC RNA m6A modification and expression in colorectal cancer. | Int J Biol Macromol | 2026 | 41349747 | PubTator, text mining | PubMed |
| HPD is an m6A Methyltransferase that Protects Colorectal Cancer Cells from Ferroptotic Cell Death by m6A Methylating SLC7A11/GPX4. | Adv Sci (Weinh) | 2026 | 41317403 | PubTator, text mining | PubMed |
| METTL14 Inhibits Human Lung Microvascular Endothelial Cell From Ferroptosis in Septic Lung Injury by Regulating N6-Methyladenosine-Modified ACSL4 Level. | Clin Exp Pharmacol Physiol | 2026 | 41312681 | PubTator, text mining | PubMed |
| EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathway. | J Clin Invest | 2026 | 41252201 | PubTator, text mining | PubMed |
| Ferroptosis modulation by METTL14 in cancers: From molecular insights to therapeutic strategies. | Cell Signal | 2026 | 41203185 | PubTator, text mining | PubMed |
| METTL14 integrates tumor-derived SAM to drive parabrachial epigenetic rewiring in pancreatic cancer. | Neuron | 2026 | 41192426 | PubTator, text mining | PubMed |
| TGFBR2 Accelerates the Oxidative Stress and Inflammation in Septic Acute Lung Injury VIA METTL14-MEDIATED M6A Modification or USP7-REGULATED Deubiquitination. | Shock | 2026 | 41166067 | PubTator, text mining | PubMed |
| m6A mRNA methylation initiated by METTL14 promotes STK11 translation and increases STK11 activity to induce anti-HER2 therapy resistance in breast cancer. | Biochim Biophys Acta Mol Basis Dis | 2026 | 40885342 | PubTator, text mining | PubMed |
| METTL14/IGF2BP2-mediated m6A modification of PD-L1 promotes proliferation, metastasis, and immune escape in high-grade gliomas. | J Neuropathol Exp Neurol | 2026 | 40796110 | PubTator, text mining | PubMed |
| METTL14 Promotes the Osteogenic Differentiation of Human Bone Marrow Stromal Cells via m6A-Dependent Stabilization of USP7 mRNA. | Biochem Genet | 2026 | 39815132 | PubTator, text mining | PubMed |
| CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy. | RNA Nanomed | 2025 | 42004278 | PubTator, text mining | PubMed |
| Inhibition of Clostridioides difficile-specific DNA adenine methyltransferase CamA by analogs of S-adenosyl-l-methionine. | bioRxiv | 2025 | 41669157 | PubTator, text mining | PubMed |
| Interplay between hypoxia, RNA methylation, and HPV in head and neck squamous cell carcinomas: drivers of oncogenesis and resistance to therapy. | EXCLI J | 2025 | 41624157 | PubTator, text mining | PubMed |
| Machine learning-based comprehensive analysis of m6A RNA methylation regulators in colorectal cancer: implications for prognosis, immune microenvironment, and immunotherapy response. | Exp Biol Med (Maywood) | 2025 | 41613364 | PubTator, text mining | PubMed |
| m6A epigenetic signature in necrotizing enterocolitis: insights from murine to neonatal studies. | Front Immunol | 2025 | 41613127 | PubTator, text mining | PubMed |
| Targeted RNA base editing for therapeutic: mechanisms and advances. | Pharm Sci Adv | 2025 | 41550651 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=10